Risk Factors Of Acute Pulmonary Embolism In Different Age Groups

Purpose:In recent years,with the gradual recognition of clinicians on the disease of pulmonary embolism,the development of CTPA and other diagnostic techniques and the prevalence of pulmonary embolism have increased year by year.According to the diagnosis and treatment of pulmonary embolism recommended by the ?Pulmonary Thrombosis Diagnosis and Prevention Guide?,the risk factors of pulmonary embolism are particularly important in the diagnosis,diagnosis,cause and risk stratification strategies.From recent guidelines for pulmonary embolism at home and abroad,it can be seen that risk factors play a very important role in the prevention,diagnosis,and treatment of anticoagulant therapy during treatment.This study,through the statistical analysis of risk factors in different age groups,aims to guide the bed diagnosis and treatment work,to achieve early diagnosis,active treatment,judgment,and prevention of recurrence.Method:From January 2015 to June 2016,160 patients with APE diagnosed in the Department of Respiratory and Critical Care Medicine,General Hospital of Tianjin Medical University were retrospectively analyzed for risk factors.The risk factors were analyzed retrospectively.The age group was divided into the elderly group and the middle-aged group.To explore the characteristics of risk factors for APE patients hospitalized in different ages.Result:Acute infection and/or rheumatic diseases were the most common risk factors in the young and middle-aged groups,and there were no significant differences between the two groups;elderly patients with central failure and / or respiratory failure,acute myocardial infarction or ischemic stroke Acute pulmonary embolism caused by risk factors was common in the young and middle-aged group,and the difference was statistically significant(P<0.05).However,the known thrombophilia and acute pulmonary embolism caused by these risk factors are currently undergoing hormone therapy.The younger and middle-aged groups were more common,and the differencewas statistically significant(P<0.05).According to the risk stratification of acute pulmonary embolism,in the middle-high-risk and high-risk groups,the elderly group was more common than the younger and younger patients,the difference was statistically significant(P<0.05);in the low-risk group,young and middle-aged There were more patients in the group than in the elderly group,and the difference was statistically significant(P<0.05).Inconclusion:PTE is one of the major cardiovascular emergencies that threaten human health,and its incidence,mortality and misdiagnosis rate are high.The incidence and mortality of different age groups are different.The risk factors involved in this study included active cancer(patients with local or distant metastases and/or received radiotherapy within 6 months),previous history of VTE,decreased activity(at least 3 days in bed),known susceptibility Sputum(hereditary antithrombin deficiency,hereditary PS,PC deficiency,clotting factor V Leiden mutation),recent trauma or / and surgical history,heart failure and / or respiratory failure,acute Myocardial infarction or ischemic stroke,acute infection and or rheumatic disease,obesity.Acute pulmonary embolism caused by two risk factors: central failure and/or respiratory failure,acute myocardial infarction or ischemic stroke is more common in the elderly group than in the young and middle-aged group;and known thrombophilia,which are currently undergoing hormone therapy Acute pulmonary embolism due to risk factors is more common in the young and middle-aged group.According to the above results,clinicians in the elderly patients with heart failure and / or respiratory failure,acute myocardial infarction or ischemic stroke risk factors should be highly alert to the occurrence of acute pulmonary embolism,to achieve positive prevention,early diagnosis of reasonable anticoagulation plan.In the face of young and middle-aged patients who have been identified with thrombophilia and who are currently undergoing hormone therapy,they should also actively prevent and diagnose early anticoagulant programs.Thereby reducing the incidence of pulmonary embolism,mortality,and improving the prognosis of pulmonary embolism.